Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-06
DOI
10.1038/s41416-020-0971-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis of new derivatives of boehmeriasin A and their biological evaluation in liver cancer
- (2019) Ece Akhan Güzelcan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells
- (2019) Dongdong Luo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Spa-RQ: an Image Analysis Tool to Visualise and Quantify Spatial Phenotypes Applied to Non-Small Cell Lung Cancer
- (2019) Jie Bao et al. Scientific Reports
- Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis
- (2018) Sivesh K. Kamarajah Asian Journal of Surgery
- Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis
- (2018) Ken Shirabe et al. JOURNAL OF GASTROENTEROLOGY
- No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm
- (2018) Kayvan Mohkam et al. JOURNAL OF HEPATOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
- (2018) Shanshan Wang et al. Cell Death & Disease
- Hepatic stellate cells secreting WFA+ -M2BP: Its role in biological interactions with Kupffer cells
- (2017) Yuki Bekki et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins
- (2017) Mariko Tsukagoshi et al. Oncotarget
- Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)
- (2016) D. Koeberle et al. ANNALS OF ONCOLOGY
- Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers
- (2016) Suzanne van Meer et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Clinical significance of serumWisteria floribundaagglutinin positive Mac-2-binding protein level in non-alcoholic steatohepatitis
- (2016) Hiroki Nishikawa et al. HEPATOLOGY RESEARCH
- Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma
- (2016) Andrew X. Zhu et al. JOURNAL OF HEPATOLOGY
- Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development
- (2016) Seung Up Kim et al. LIVER INTERNATIONAL
- A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation
- (2016) Hiroki Nishikawa et al. MEDICINE
- Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis
- (2015) Takeji Umemura et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics
- (2015) Hisashi Narimatsu Expert Review of Proteomics
- Serum WFA+-M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection
- (2015) Hidenori Toyoda et al. LIVER INTERNATIONAL
- CAGEr: precise TSS data retrieval and high-resolution promoterome mining for integrative analyses
- (2015) Vanja Haberle et al. NUCLEIC ACIDS RESEARCH
- mTOR inhibitor therapy: Does it prevent HCC recurrence after liver transplantation?
- (2015) Christophe Duvoux et al. Transplantation Reviews
- A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis
- (2014) Takeo Toshima et al. JOURNAL OF GASTROENTEROLOGY
- Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
- (2014) Shan-Shan Jiang et al. Journal of Translational Medicine
- CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression
- (2014) L Lin et al. Cell Death & Disease
- Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: Implications for the treatment of human liver cancer
- (2013) Chunmei Wang et al. CELL CYCLE
- The burden of liver disease in Europe: A review of available epidemiological data
- (2013) Martin Blachier et al. JOURNAL OF HEPATOLOGY
- A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis
- (2013) Atsushi Kuno et al. Scientific Reports
- Overexpression of galectin-3 enhances migration of colon cancer cells related to activation of the K-Ras–Raf–Erk1/2 pathway
- (2012) Keng-Liang Wu et al. JOURNAL OF GASTROENTEROLOGY
- Galectin-3 stabilizes heterogeneous nuclear ribonucleoprotein Q to maintain proliferation of human colon cancer cells
- (2009) B. C. Yoo et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma
- (2008) Yasunori Matsuda et al. HEPATOLOGY RESEARCH
- Discovering Sequence Motifs with Arbitrary Insertions and Deletions
- (2008) Martin C. Frith et al. PLoS Computational Biology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now